Proteostasis Therapeutics, Inc.
$40 Million - Follow-OnJoint Bookrunner
Fate Therapeutics, Inc.
$46 Million - Follow-OnJoint Bookrunner
$74 Million - Initial Public OfferingJoint Bookrunner
BDX / Mgmt. Meeting Takeaways; BCR Deal Close & EPS Accretion Around the Corner
HCIT & Distribution / Amazon: We Estimate That It’s a Matter of When, Not If
Biopharma / AML – Will All the New Drugs Amount to More Than Niches?